Trinity Biotech PLC Financial Report: Key Credit Agreement Updates & Compliance Insights

Here are the key insights extracted from the financial report (Form 6-K) for Trinity Biotech PLC:

1. Company Information:

• Name: Trinity Biotech PLC
• Address: IDA Business Park, Bray, Co. Wicklow, Ireland

2. Filing Type:

• This report is a Form 6-K filed under the Securities Exchange Act of 1934.

3. Filing Date:

• The report is dated December 26, 2024.

4. Credit Agreement Update:

• On December 23, 2024, Trinity Biotech and its subsidiaries amended and restated their Credit Agreement and Guaranty.
• The agreement governs a term loan facility with Perceptive Credit Holdings III, L.P.
• Additionally, Trinity Biotech amended the warrant certificates issued to Perceptive and issued new warrants to Perceptive and its affiliates.

5. Purpose of Amendments:

• The amendments are likely aimed at enhancing liquidity and supporting Trinity's transformation plan.

6. Exhibits Included:

• Exhibit 99.1: Third Amended and Restated Credit Agreement and Guaranty dated December 23, 2024.
• Exhibit 99.2: Press release announcing the amended credit agreement.

7. Registration Statements:

• The Form 6-K is being incorporated by reference into various Registration Statements on Form F-3 and Form S-8, indicating ongoing securities offerings or employee benefit plans.

8. Regulatory Compliance:

• The report indicates compliance with rules regarding submission in paper format and furnishing information to the Commission.

9. Signatory:

• The report is signed by Louise Tallon, Chief Financial Officer of Trinity Biotech PLC.

This summary highlights the significant updates regarding financial agreements and regulatory compliance for Trinity Biotech PLC, which may be relevant for investors and stakeholders monitoring the company's financial health and strategic direction.